, Tracking Stock Market Picks
Enter Symbol:
Oramed Pharmaceuticals, Inc. (ORMP) [hlAlert]

down 27.08 %

Oramed Pharmaceuticals, Inc. (ORMP) rated Buy with price target $35 by Aegis Capital

Posted on: Thursday,  Jan 30, 2014  9:25 AM ET by Aegis Capital

Aegis Capital rated Buy Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) on 01/30/2014. Previously Aegis Capital rated Buy Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) on
12/03/2013., when the stock price was $8.16. Since then, Oramed Pharmaceuticals, Inc. has lost 27.08% as of 12/01/2015's recent price of $5.95.
If you would have followed the previous Aegis Capital's recommendation on ORMP, you would have lost 27.08% of your investment in 728 days.

Oramed Pharmaceuticals Inc. (Oramed) is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, rectal application of insulin, use of oral ingestible capsules or tablets for delivery other polypeptides and use of rectal application for delivery of other polypeptides. As of August 31, 2009, the Company had not generated any revenues.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2014 9:25 AM Buy
24.94 35.00
as of 10/17/2014
1 Week up  1.09 %
1 Month down  -17.11 %
3 Months down  -12.48 %
1 YTD down  -52.30 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/3/2013 10:25 AM Buy
8.16 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy